Razzak Abrahim N, Janardan Abhishek, Shah Ipsit, Jha Pinky, Abdelgadir Yasir
School of Medicine, Medical College of Wisconsin, Milwaukee, USA.
Internal Medicine, Medical College of Wisconsin, Milwaukee, USA.
Cureus. 2022 Jun 3;14(6):e25635. doi: 10.7759/cureus.25635. eCollection 2022 Jun.
Multisystem inflammatory syndrome in an adult (MIS-A) is a rare immunological complication that gained prominence after the coronavirus disease 2019 pandemic. Patients with MIS-A often clinically present with non-specific generalized symptoms, such as fever, myalgia, or fatigue, making the diagnosis difficult. In this article, we present an unusual case of MIS-A in a 50-year-old male that raises the question of whether the immune system's dysregulation will demonstrate differing criteria of signs and symptoms for a patient on sustained immunosuppression as opposed to the non-immunosuppressed population.
成人多系统炎症综合征（MIS-A）是一种罕见的免疫并发症，在2019年冠状病毒病大流行后受到关注。MIS-A患者临床上常表现为非特异性全身症状，如发热、肌痛或疲劳，这使得诊断困难。在本文中，我们介绍了一例50岁男性的罕见MIS-A病例，该病例引发了一个问题：与未接受免疫抑制的人群相比，持续接受免疫抑制治疗的患者免疫系统失调是否会表现出不同的体征和症状标准。
